Stem Cells
Nuclear Reprogramming and Therapeutic Applications. No. 265
Will be published approx. on 18. March 2005
Book
Hardback
230 pages
978-0-470-09143-2 (ISBN)
Description
This book focuses on the factors that maintain stem cells in a pluripontent state or drive them to create differentiated and lineage-committed cells in vitro and in vivo.
* Gives a comprehensive overview of current issues in stem cell research
* Unites a general consideration of stem cell research with a specific concentration on the key issue of nuclear reprogramming
* Discusses important ethical and policy issues which create the framework within which scientists carry out stem cell research
* Contributions from leading figures in the field
Reviews / Votes
"...this book provides: a comprehensive overview of current issues in stem cell research, with contributions from leading figures in the field..." (British Society of Cell Biology, January 2006) "This compact book is easy to read...[discussions] provide insights into the practice of science as a deeply human enterprise. I learned a great deal." (Doody's Health Services)'This book is an essential purchase for all those engaged in stem cell research, whether in the laboratory or the clinic.' (Anticancer Research, 2007)
More details
Product info
gebunden
Series
Edition
1. Auflage
Language
English
Place of publication
New York
United States
Target group
Professional and scholarly
Product notice
sewn/stitched
Cloth over boards
Dimensions
Height: 235 mm
Width: 157 mm
Thickness: 18 mm
Weight
535 gr
ISBN-13
978-0-470-09143-2 (9780470091432)
Schweitzer Classification
Other editions
Additional editions
E-Book
09/2005
Wiley
€166.99
Available for download
Person
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Content
Chair's Introduction (John Gearhart).
What is a stem cell ? Discussion (Davor Solter).
Bone-marrow derived hepatocytes - Discussion (Markus Grompe).
Normal and neoplastic stem cells - Discussion (Irvin L. Weissman).
Multipotent adult progenitor cells: an update - Discussion (Catherine A. Verfaillie).
Neural progenitor cells of the adult brain - Discussion (Steven A. Goldman and Fraser Sim).
Stem cells in the brain - General Discussion I.
Embryonic stem cells: a perspective - Discussion (Martin Evans).
Nuclear cloning, epigenetic reprogramming and cellular differentiation - Discussion (Rudolf Jaenisch, Konrad Hochedlinger and Kevin Eggan).
General Discussion II.
Nuclear reprogramming by xenopus oocytes - Discussion (J.B. Gordon, J.A. Byrne and S. Simonsson).
Cardiac stem cells and myocardial regeneration - Discussion (Bernardo Nadal-Ginard, Perio Anversa, Jan Kajstura and Annarosa Leri).
Genenration of insulin-producing cells from stem cells - Discussion (Bernat Soria, Enrique Roche, Juan A. Reig and Franz Martin).
Cell therapy for Parkinson's disease: problems and prospects - Discussion (Anders Bjorklund).
Ethical (and political) issues in research with human stem cells - Discussion (Thomas H. Murray).
The regulatory environment - final discussion.
Index of contributors.
Subject index.